India RNA Therapeutics Market to Grow with a CAGR of 6.23% through 2030
Rising demand
for personalized medicine is expected to drive the India RNA Therapeutics
Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India RNA Therapeutics Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India RNA
Therapeutics Market stood at USD 48.91 Million in 2024 and is anticipated to
grow with a CAGR of 6.23% through 2030. The
Indian government has been proactively fostering a conducive environment for
RNA therapeutics through initiatives aimed at building infrastructure,
advancing R&D capabilities, and ensuring accessibility. The establishment
of biotechnology parks across the country has provided state-of-the-art
facilities for RNA research, attracting global and domestic investments.
Collaborations between government institutions like the Department of
Biotechnology (DBT) and international organizations have accelerated
RNA-focused projects, especially in vaccine development and genetic disorder
treatments. Furthermore, the government's emphasis on self-reliance under the
"Aatmanirbhar Bharat" campaign has encouraged local companies to
invest in RNA therapeutic innovations, reducing dependency on imports. This
integrated approach is not only addressing public health challenges but also
boosting India's standing in the global RNA therapeutics landscape.
The
rising demand for personalized medicine is emerging as a significant driver in
the RNA therapeutics market, revolutionizing how diseases are treated and
managed. Personalized medicine tailors treatments to an individual’s unique genetic
makeup, enabling targeted and effective therapies. RNA-based technologies, such
as mRNA vaccines and RNA interference (RNAi) therapeutics, are at the forefront
of this shift, as they allow precise modulation of gene expression to address
specific genetic mutations and disease pathways. This approach has gained
traction in the treatment of cancer, rare genetic disorders, and infectious
diseases, where conventional therapies often fall short.
In
India, the increasing prevalence of chronic and genetic diseases has
intensified the demand for personalized therapies. Additionally, advancements
in genomics and next-generation sequencing have made it easier to identify
disease-causing mutations, enabling the development of RNA-based therapeutics
tailored to individual patient profiles. The availability of sophisticated
diagnostic tools and growing awareness among healthcare providers and patients
about the benefits of personalized treatments further contribute to this trend.
This surge in demand is driving innovation and investment in the RNA
therapeutics space, positioning personalized medicine as a cornerstone of
modern healthcare in India.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India RNA Therapeutics Market”
The India RNA
Therapeutics Market is segmented into product, type, indication, end user, regional
distribution, and company.
Based
on Product, Vaccines have emerged as the fastest growing segment in the India
RNA Therapeutics Market during the forecast period due
to their revolutionary success and scalability, particularly highlighted during
the COVID-19 pandemic. RNA-based vaccines, such as mRNA vaccines, have
demonstrated unparalleled speed in development and production, enabling rapid
responses to emerging infectious diseases. This success has not only reinforced
the potential of RNA vaccines but also driven significant investments and
research into expanding their applications beyond COVID-19, targeting diseases
such as influenza, HIV, and even cancer.
Based on Region,
South India have emerged as the fastest growing region in the India RNA
Therapeutics Market in 2024. This
growth is driven by the region's advanced biotechnology infrastructure, strong
academic and research institutions, and significant investments in the
pharmaceutical sector. Cities like Bengaluru, Hyderabad, and Chennai serve as
hubs for biotech innovation, with Hyderabad being home to Genome Valley, a
global center for biotech research and manufacturing. The region's focus on
RNA-based research, government support through initiatives like the
Biotechnology Industry Research Assistance Council (BIRAC), and the presence of
leading biotech companies are accelerating its growth. Additionally,
collaborations between academia and industry in South India are fostering
advancements in RNA therapeutics, contributing to its rapid expansion.
Major companies
operating in India RNA Therapeutics Market are:
- Pfizer Limited
- Novartis AG
- Sanofi S.A.
- Biocon Ltd Company
- Gennova Biopharmaceuticals Ltd.
- Cipla Limited
- Dr. Reddy's Laboratories
- Sun Pharmaceutical Industries Ltd.
- Bharat Biotech
- Serum Institute of India
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The surge in mRNA vaccine development post-COVID-19
has significantly reshaped the landscape of RNA therapeutics, with mRNA
technology emerging as a game-changer in global healthcare. The unprecedented
success of mRNA-based COVID-19 vaccines, such as those by Pfizer-BioNTech and
Moderna, demonstrated the potential of this technology to be rapidly deployed,
highly effective, and adaptable to emerging infectious diseases. This success
has fueled massive investments and research into developing mRNA vaccines for
other infectious diseases like influenza, HIV, Zika virus, and even certain
types of cancer.”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“India RNA Therapeutics
Market By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA
Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics,
Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary
Diseases, Other), By End User (Hospitals and Clinics, Research Settings), By
Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India RNA Therapeutics Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India RNA Therapeutics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com